In sickle cell anemia there is substitution of
First, I know that sickle cell anemia is a genetic disorder caused by a mutation in the beta-globin gene. The mutation is a point mutation where a single nucleotide is changed. Specifically, thymine is replaced by adenine in the DNA, leading to the substitution of valine for glutamic acid at the sixth position of the beta-globin chain. This results in abnormal hemoglobin, known as HbS.
So the core concept here is the molecular basis of sickle cell anemia. The substitution is a single nucleotide polymorphism causing a change in the amino acid sequence. The correct answer should be the substitution of glutamic acid with valine at position 6 of the beta-globin chain.
Wait, the options might have been about which amino acid is substituted. If the options were like A. Valine for glutamic acid, B. Glutamic acid for valine, etc., then the correct answer would be B. But since the user hasn't provided the options, I need to structure the explanation around the known fact.
In the explanation, I need to detail that the mutation is a point mutation in the beta-globin gene, leading to the substitution of glutamic acid (a polar amino acid) with valine (a non-polar amino acid) at the sixth position. This causes the hemoglobin to polymerize under low oxygen conditions, leading to the sickle shape of red blood cells.
For the wrong options, if someone thought it was another substitution, like lysine instead of glutamic acid, that's incorrect because the correct substitution is valine. Similarly, if the position was different, like position 5 instead of 6, that's wrong. Also, if the substitution was in the alpha-globin chain, that's a different condition, like alpha-thalassemia.
The clinical pearl here is to remember that the "6th position substitution" is key for sickle cell. The mnemonic could be "Glu to Val at 6" helps in remembering. Also, understanding that this is an autosomal recessive disorder and the importance of hemoglobin electrophoresis in diagnosis.
Putting it all together, the correct answer is the substitution of glutamic acid with valine at the sixth position of the beta-globin chain. The explanation should cover the molecular mechanism, why the other options are wrong (like different positions or other amino acids), and highlight the clinical significance.
**Core Concept**
Sickle cell anemia results from a point mutation in the **beta-globin gene (HBB)** on chromosome 11. This leads to substitution of **glutamic acid** (a polar, negatively charged amino acid) with **valine** (a non-polar, hydrophobic amino acid) at the **6th position** of the beta-globin chain. This mutation causes abnormal hemoglobin (HbS), leading to sickle-shaped red blood cells under hypoxic conditions.
**Why the Correct Answer